Publications by authors named "Peter Dale"

Claim this Profile
C
Cost-effectiveness analysis of nivolumab plus ipilimumab plus two cycles of platinum-doublet chemotherapy versus platinum-doublet chemotherapy alone for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United States.
Maria Polyzoi, Hera Sandhu, Johan Maervoet, Yong Yuan, Mohammad A Chaudhary, Peter Dale

J Med Econ· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of nivolumab plus ipilimumab versus platinum-doublet chemotherapy for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United States.
Malin Berling, Mohammad A Chaudhary, Yong Yuan, Nebibe Varol, Peter Dale

J Med Econ· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of nivolumab in squamous and non-squamous non-small cell lung cancer in Canada and Sweden: an update with 5-year data.
Mohammad A Chaudhary, Christoffer Holmberg, Khalid Lakhdari, Caitlin Smare, Chloi Theriou, Peter Dale

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR inhibitors reduce enteropathy, intestinal bleeding and colectomy rate in patients with juvenile polyposis of infancy with PTEN-BMPR1A deletion.
Henry Taylor, Dilay Yerlioglu, Claudia Phen, Antje Ballauff, Natalia Nedelkopoulou, Peter Dale

Hum Mol Genet· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care.
Uma Ramaswami, Steve E Humphries, Lorraine Priestley-Barnham, Peter Green, David S Wald, Peter Dale

Atherosclerosis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1-year growth data.
Steve E Humphries, Jackie Cooper, Peter Dale, Uma Ramaswami,

J Clin Lipidol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the effect of beliefs about asthma medication and treatment intrusiveness on adherence and preference for once-daily vs. twice-daily medication.
Sarah Chapman, Peter Dale, Henrik Svedsater, Gillian Stynes, Nicola Vyas

NPJ Prim Care Respir Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement properties of an asthma symptom and rescue medication use diary.
Marci Clark, Susan Martin, Henrik Svedsater, Peter Dale, Loretta Jacques

J Asthma· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries.
David Price, Peter Dale, Emma Elder, Kenneth R Chapman

J Asthma· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
Henrik Svedsater, Peter Dale, Karl Garrill, Richard Walker, Mark W Woepse

BMC Pulm Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What do we know about asthma triggers? a review of the literature.
Margaret K Vernon, Ingela Wiklund, Jill A Bell, Peter Dale, Kenneth R Chapman

J Asthma· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An electronic diary is shown to be more reliable than a paper diary: results from a randomized crossover study in patients with persistent asthma.
Andrea M Ireland, Ingela Wiklund, Ray Hsieh, Peter Dale, Erin O'Rourke

J Asthma· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of sorafenib in the treatment of hepatocellular carcinoma in Canada.
Noemi Muszbek, Sonalee Shah, Stuart Carroll, Heather McDonald, Peter Dale

Curr Med Res Opin· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Questioning the economic evaluation of omalizumab.
Dennis Revicki, Ruth Brown, Peter Dale

J Allergy Clin Immunol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis